| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC0917 |
| Trial ID | ChiCTR2100043251 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA CAR-T cells |
| Co-treatment | allogeneic hematopoietic stem cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Fully human BCMA CAR T cells from related donors combined with allogeneic hematopoietic stem cells: single-center, open, non-randomized, single-arm clinical trial of transplantation for refractory/relapsed multiple myeloma |
| Year | 2021 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Cohort 1 | |||||||
|
|||||||